Publication | Open Access

Inhibiting corneal neovascularization by sustainably releasing anti-VEGF and anti-inflammation drugs from silica-thermogel nanohybrids

Tissue EngineeringNanomedicineEngineeringOphthalmologyTherapeutic NanomaterialsMedicineSilica-thermogel NanohybridsTopical DrugVascular BiologyNano-drug DeliveryWound HealingNeovascularizationPharmacologyAnti-inflammation DrugsCorneal Neovascularization